[Geniculate ganglion tumors. Therapeutic and reconstructive management]

J A González García1, O Arenas Brítez, R Gil Carrasco

  • 1Servicio de Otorrinolaringología, Hospital General Universitario Gregorio Marañón, Madrid. tirititet@hotmail.com

Insights

Surgical resection of geniculate ganglion tumors, often benign, can restore facial nerve function. Techniques include nerve grafts and anastomosis, with palliative options when resection is not feasible.

Area of Science:

  • Neurosurgery
  • Otolaryngology
  • Oncology

Background:

  • Geniculate ganglion tumors are rare lesions affecting the facial nerve.
  • Early diagnosis and intervention are crucial for preserving facial nerve function.

Observation:

  • Five cases of geniculate ganglion tumors (3 neurinomas, 2 hemangiomas) are presented.
  • Patients presented with facial nerve paralysis or paresis.
  • Various surgical approaches were utilized, including trans-mastoid, middle fossa, and combined routes.

Findings:

  • Total tumor resection was the primary treatment goal.
  • Facial nerve reconstruction involved termino-terminal grafts and facial-hypoglossus anastomosis.
  • Functional outcomes, graded by the House-Brackmann scale, varied, with some grafts achieving Grade III function.
  • Palliative treatment with a gold plaque was used when resection was not possible.

Implications:

  • Complete resection is the mainstay for benign geniculate ganglion tumors.
  • Nerve reconstruction techniques, including grafting and anastomosis, can yield functional recovery.
  • Palliative measures are essential for managing unresectable tumors to improve quality of life.

Related Concept Videos